Want to see AU:BLS full AI Analyst Report?
Total Valuation
Bioxyne Limited has a market cap or net worth of AU$206.19M. The enterprise value is AU$228.67M.
Market CapAU$206.19M
Enterprise ValueAU$228.67M
Share Statistics
Bioxyne Limited has 229,103,590 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding229,103,590
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Bioxyne Limited’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.
Return on Equity (ROE)―
Return on Assets (ROA)―
Return on Invested Capital (ROIC)―
Return on Capital Employed (ROCE)―
Revenue Per Employee―
Profits Per Employee―
Employee Count16
Asset Turnover―
Inventory Turnover―
Valuation Ratios
The current PE Ratio of Bioxyne Limited is 23.1. Bioxyne Limited’s PEG ratio is -0.13.
PE Ratio23.1
PS Ratio2.90
PB Ratio7.54
Price to Fair Value―
Price to FCF22.82
Price to Operating Cash Flow―
PEG Ratio-0.13
Income Statement
In the last 12 months, Bioxyne Limited had revenue of ― and earned ― in profits. Earnings per share was ―.
Revenue―
Gross Profit―
Operating Income―
Pretax Income―
Net Income―
EBITDA―
Earnings Per Share (EPS)―
Cash Flow
In the last 12 months, operating cash flow was ― and capital expenditures ―, giving a free cash flow of ― billion.
Operating Cash Flow―
Free Cash Flow―
Free Cash Flow per Share―
Dividends & Yields
Bioxyne Limited pays an annual dividend of ―, resulting in a dividend yield of ―
Dividend Per Share―
Dividend Yield―
Payout RatioN/A
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta1.56
52-Week Price Change100.00%
50-Day Moving Average0.83
200-Day Moving Average0.55
Relative Strength Index (RSI)51.07
Average Volume (3m)4.35M
Important Dates
Bioxyne Limited upcoming earnings date is ―, ―.
Last Earnings Date―
Next Earnings Date―
Ex-Dividend Date―
Financial Position
Bioxyne Limited as a current ratio of ―, with Debt / Equity ratio of ―
Current Ratio―
Quick Ratio―
Debt to Market Cap―
Net Debt to EBITDA―
Interest Coverage Ratio―
Taxes
In the past 12 months, Bioxyne Limited has paid ― in taxes.
Income Tax―
Effective Tax Rate―
Enterprise Valuation
Bioxyne Limited EV to EBITDA ratio is ―, with an EV/FCF ratio of ―.
EV to Sales―
EV to EBITDA―
EV to Free Cash Flow―
EV to Operating Cash Flow―
Balance Sheet
Bioxyne Limited has ― in cash and marketable securities with AU$7.43M in debt, giving a net cash position of ― billion.
Cash & Marketable Securities―
Total DebtAU$7.43M
Net Cash―
Net Cash Per Share―
Tangible Book Value Per Share―
Margins
Gross margin is ―, with operating margin of ―, and net profit margin of ―.
Gross Margin―
Operating Margin―
Pretax Margin―
Net Profit Margin―
EBITDA Margin―
EBIT Margin―
Analyst Forecast
The average price target for Bioxyne Limited is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast174.51%
EPS Growth Forecast265.77%